Artiva Biotherapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-140.7M | $102.8M |
| Mar 2023 | — | $-155.6M | — |
| Jun 2023 | — | $-164.3M | $53.7M |
| Sep 2023 | — | $-151.5M | $65.9M |
| Dec 2023 | — | $-162.0M | $53.5M |
| Mar 2024 | — | $-174.7M | $48.2M |
| Jun 2024 | — | $-191.1M | $34.2M |
| Sep 2024 | — | $201.0M | $55.9M |
| Dec 2024 | — | $186.6M | $40.2M |
| Mar 2025 | — | $168.8M | $30.4M |
| Jun 2025 | — | $149.0M | $28.5M |
| Sep 2025 | — | $129.2M | $25.5M |
| Dec 2025 | — | $110.0M | $26.7M |
| Mar 2026 | — | $87.8M | $21.0M |
| Jun 2026 | — | $347.5M | $301.5M |